Research in Mayo Clinic's Liver Disease Immunobiology Lab led by Petra Hirsova, Pharm.D., Ph.D., focuses on metabolic dysfunction-associated steatohepatitis.

A new study offers hope for earlier detection for fatty liver disease. This new blood test claims to predict it 16 years ...

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

Researchers in South Korea have developed an organoid disease model and non-destructive stiffness analysis technology for ...

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, critical role in dampening ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

These events are associated with innate training and can have long-term impacts on hematopoietic stem and progenitor cell (HSPC) development but can also compromise their function. While many ...

A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

HepatoBurn is a dietary supplement that uses an organic blend of ingredients to restore the detoxifying and fat-burning ...